Corestem Inc (166480)

Currency in KRW
4,425
+720(+19.43%)
Delayed Data·
Unusual trading volume
Trading near 52-week High
166480 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,6504,495
52 wk Range
1,0144,495
Key Statistics
Bid/Ask
4,420.00 / 4,430.00
Prev. Close
3,705
Open
3,705
Day's Range
3,650-4,495
52 wk Range
1,014-4,495
Volume
2.43M
Average Volume (3m)
607.98K
1-Year Change
28.9474%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
166480 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Corestem Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 19, 2026
EPS / Forecast
-256.43 / --
Revenue / Forecast
4.95B / --
EPS Revisions
Last 90 days

166480 Income Statement

Compare 166480 to Peers and Sector

Metrics to compare
166480
Peers
Sector
Relationship
P/E Ratio
−6.1x−12.8x−0.6x
PEG Ratio
−0.28−0.150.00
Price/Book
3.0x3.5x2.6x
Price / LTM Sales
8.2x13.4x3.2x
Upside (Analyst Target)
-26.1%48.1%
Fair Value Upside
Unlock13.1%5.8%Unlock

CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases. The company has a strategic partnership with ATG Lifetech to deliver precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures. The company was formerly known as Corestem, Inc. CORESTEMCHEMON Inc. was founded in 2003 and is based in Seongnam-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.34K0.04%60.53M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
44.34M99.96%164.30B
Total
44.36M100.00%164.36B

FAQ

What Is the Corestem (166480) Stock Price Today?

The Corestem stock price today is 4,425 KRW.

What Stock Exchange Does Corestem Trade On?

Corestem is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Corestem?

The stock symbol for Corestem is "166480."

What Is the Corestem Market Cap?

As of today, Corestem market cap is 164.35B KRW.

What Is Corestem's Earnings Per Share (TTM)?

The Corestem EPS (TTM) is -903.

From a Technical Analysis Perspective, Is 166480 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Corestem Stock Split?

Corestem has split 0 times.

How Many Employees Does Corestem Have?

Corestem has 36 employees.

What is the current trading status of Corestem (166480)?

As of May 08, 2026, Corestem (166480) is trading at a price of 4,425 KRW, with a previous close of 3,705 KRW. The stock has fluctuated within a day range of 3,650 KRW to 4,495 KRW, while its 52-week range spans from 1,014 KRW to 4,495 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.